JonesTrading Downgrades POINT Biopharma Global to Hold
Portfolio Pulse from Benzinga Newsdesk
JonesTrading analyst Justin Walsh has downgraded POINT Biopharma Global (NASDAQ:PNT) from Buy to Hold.
October 04, 2023 | 11:13 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
POINT Biopharma Global's stock rating has been downgraded from Buy to Hold by JonesTrading.
The downgrade from Buy to Hold by JonesTrading analyst Justin Walsh indicates a less optimistic outlook for the company's stock in the short term. This could potentially lead to a decrease in the stock's price as investors may interpret this as a signal to sell or avoid buying the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100